Related Experiment Videos
Bone marrow transplantation in DiGeorge syndrome
The Journal of Pediatrics
|July 1, 1987
Summary
Bone marrow transplantation (BMT) successfully treated a Hispanic infant with DiGeorge syndrome and severe immunodeficiency. This indicates BMT can be a viable treatment option for DiGeorge syndrome patients with T cell deficiency.
Area of Science:
- Immunology
- Pediatric Hematology/Oncology
- Genetics
Background:
- DiGeorge syndrome is characterized by severe T and B cell immunodeficiency.
- Traditional treatments like thymic factors showed limited efficacy in this patient.
- Bone marrow transplantation (BMT) was considered due to the patient's deteriorating condition.
Observation:
- A Hispanic infant presented with typical DiGeorge syndrome features, including cardiac defects and hypoparathyroidism.
- The patient exhibited profound T and B cell immunodeficiency and low serum facteur thymique serique (FTS) levels.
- In vitro thymosin alpha 1 treatment did not improve T cell numbers.
Findings:
- Successful BMT was performed using a histocompatible sibling donor.
- The patient showed significant clinical and immunological improvement post-BMT.
- Evidence of T cell engraftment, enhanced B cell function, and increased serum FTS levels were observed.
Implications:
- This case demonstrates that minimal thymic influence is sufficient for successful BMT in DiGeorge syndrome.
- BMT offers a promising therapeutic strategy for DiGeorge syndrome patients with significant T cell deficiencies.
- Further research into BMT for primary immunodeficiencies is warranted.